Orthofix Medical Inc. Proceeds from Long-term Lines of Credit
Orthofix Medical Inc. (OFIX) reported Proceeds from Long-term Lines of Credit of $64.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-08-05
- Orthofix Medical Inc. proceeds from long-term lines of credit for the quarter ending 2026-06-30 was $0.00.
- Orthofix Medical Inc. proceeds from long-term lines of credit for the quarter ending 2026-03-31 was $64.03M.
- Orthofix Medical Inc. proceeds from long-term lines of credit for the quarter ending 2024-12-31 was $157.60M, a 50.81% increase year-over-year.
- Orthofix Medical Inc. proceeds from long-term lines of credit for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Orthofix Medical Inc. proceeds from long-term lines of credit for fiscal 2024 was $197.60M, a 13.24% increase from fiscal 2023.
- Orthofix Medical Inc. proceeds from long-term lines of credit for fiscal 2023 was $174.50M.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $64.03M 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $64.03M 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | $157.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $157.60M derived: sum of 2 quarters · filed 2026-02-24 | $157.60M derived: sum of 3 quarters · filed 2026-02-24 | $197.60M 10-K · filed 2026-02-24 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $40.00M 10-Q · filed 2025-11-04 | $144.50M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $40.00M 10-Q · filed 2025-08-05 | $144.50M derived: sum of 3 quarters · filed 2026-02-24 | $163.50M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $40.00M 10-Q · filed 2025-05-06 | $144.50M derived: sum of 2 quarters · filed 2026-02-24 | $163.50M derived: sum of 3 quarters · filed 2026-02-24 | $169.50M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $104.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $123.50M derived: sum of 2 quarters · filed 2026-02-24 | $129.50M derived: sum of 3 quarters · filed 2026-02-24 | $174.50M 10-K · filed 2026-02-24 |
| 2023-09-30 | $19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $25.00M derived: sum of 2 quarters · filed 2024-11-07 | $70.00M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $51.00M 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $45.00M 10-Q · filed 2024-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |